Breastfeeding moderates FTO related adiposity: a birth cohort study with 30 years of follow-up.

This study assessed the association of breastfeeding with body composition at 30 years, among subjects who have been prospectively followed since birth in a southern Brazilian city. We also evaluated whether breastfeeding moderated the association between the rs9939609 variant in the FTO gene and adiposity. At 30 years, total and predominant breastfeeding were positively associated with lean mass index and inversely with visceral fat thickness. Among subjects breastfed for <1 month, all outcomes showed monotonically increasing values with additional copies of the A allele in the FTO genotype (rs9939609). Associations among subjects breastfed for one month or longer tended to be in the same direction but showed lower magnitude and were less consistent; for all outcomes. Interactions had p values ≤ 0.05 for body mass index, fat mass index and waist circumference. Even among young adults, breastfeeding moderates the association between the FTO variant rs9939609 and body composition

Mammals of a forest fragment in Cambuci municipality, state of Rio de Janeiro, Brazil

The Atlantic Forest is considered a hotspot due to its current state of vast degradation and high indexes of biodiversity. This biome has been degraded through the years by processes resulting from the Brazilian socioeconomic model of development. The seasonal semi-deciduous Atlantic Forest is a poorly studied phytophysiognomy specially degraded by human activities in the state of Rio de Janeiro. In the present study we report the results of a rapid mammalian inventory conducted in the municipality of Cambuci, in a fragment of seasonal semi-deciduous forest. We used live traps and pitfall traps to capture non-volant small mammals, and mist-nets of different lengths to collect bats. To sample medium and large-sized mammals we used camera traps. We recorded 27 mammal species in the region, of which 16 are volant mammals. We emphasize the distribution extension of Trinomys setosus in 150 km (that enabled its insertion in the species list of Rio de Janeiro) and the capture of Lonchophylla peracchii, a recently described species apparently restricted to Atlantic Forest. Both facts show the importance of the fragment for the region biodiversity

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. Findings Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. Interpretation ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials

Práticas Pedagógicas e Habilidades Sociais: Possibilidade de Pesquisa de Intervenção com Professores

Resumo As habilidades sociais são de extrema importância dentro das práticas pedagógicas, pois permitem a interação adequada em todo o contexto escolar. Pensando na subclasse específica de dar feedback, este estudo objetivou verificar se o ensino específico dessa subclasse de habilidades sociais pode auxiliar ou modificar a frequência de respostas dessa habilidade e interferir no número de solicitações dos alunos durante o período de aula. O estudo caracteriza-se por utilizar um delineamento experimental do tipo ABA e teve como participante uma professora de escola pública estadual de uma cidade do interior do Estado de São Paulo. Para a coleta de dados foram utilizados três protocolos onde eram computados os números de feedbacks e solicitações realizados por professora e alunos, respectivamente. Realizaram-se 13 sessões e o critério para o final das intervenções foi o aumento de 60% do número de feedbacks iniciais. Como resultados, verificou-se o aumento do número de feedbacks positivos

Mammals of a forest fragment in Cambuci municipality, state of Rio de Janeiro, Brazil

The Atlantic Forest is considered a hotspot due to its current state of vast degradation and high indexes of biodiversity. This biome has been degraded through the years by processes resulting from the Brazilian socioeconomic model of development. The seasonal semi-deciduous Atlantic Forest is a poorly studied phytophysiognomy specially degraded by human activities in the state of Rio de Janeiro. In the present study we report the results of a rapid mammalian inventory conducted in the municipality of Cambuci, in a fragment of seasonal semi-deciduous forest. We used live traps and pitfall traps to capture non-volant small mammals, and mist-nets of different lengths to collect bats. To sample medium and large-sized mammals we used camera traps. We recorded 27 mammal species in the region, of which 16 are volant mammals. We emphasize the distribution extension of Trinomys setosus in 150 km (that enabled its insertion in the species list of Rio de Janeiro) and the capture of Lonchophylla peracchii, a recently described species apparently restricted to Atlantic Forest. Both facts show the importance of the fragment for the region biodiversity

Nova Colinas, Maranhão State: A newly confirmed, complex impact structure in Brazil

International audienceThe Nova Colinas structure is an approximately 7 km wide, nearly circular feature centered at 07°09'33″S/46°06'30″W in Nova Colinas municipality in southwestern Maranhão State, Brazil. The area has been investigated for 40 yr and it has been suggested repeatedly that the structure could be of impact origin—without proof having been furnished. Magnetic anomaly maps depict the structure clearly with a strong, positive magnetic anomaly over the apparent rim zone. The central area is characterized by significant positive K and Th radiometric anomalies. Fieldwork showed that the structure has annular features along the outside and some prominent, structurally dissected hills in the interior. Thirty-three arenite samples were collected for petrographic analysis, mostly from within the structure. Microdeformation, in the form of cataclasis; concussion fractures related to compaction, and presence of planar fractures, feather features, and planar deformation features in quartz are reported. Three samples with a multitude of quartz grains with these microdeformations were analyzed by universal stage to determine the crystallographic orientations of planar fractures and planar deformation features. The results provide robust evidence that these microdeformation features represent shock metamorphism, with low (approximately 5-10 GPa) to moderate (10-16 and 10-20 GPa) shock levels. Thus, the Nova Colinas structure is now confirmed as a bona fide meteorite impact structure. The structure is moderately eroded, as shown by the absence of stronger shock deformation. The still limited available structural geological field evidence, paired with remote sensing and geophysical data, indicates that the innermost part of the structure may have a sizable remnant of a central uplift. The Nova Colinas impact age is only poorly constrained from stratigraphic inference to an upper limit of about 200-250 Ma

Short Report: Identification of Oropouche Orthobunyavirus in the Cerebrospinal Fluid of Three Patients in the Amazonas, Brazil

Oropouche fever is the second most frequent arboviral infection in Brazil, surpassed only by dengue. Oropouche virus (OROV) causes large and explosive outbreaks of acute febrile illness in cities and villages in the Amazon and Central-Plateau regions. Cerebrospinal fluid (CSF) samples from 110 meningoencephalitis patients were analyzed. The RNA extracted from fluid was submitted to reverse transcription-polymerase chain reaction and sequencing to identify OROV. Three CSF samples showed the presence of OROV causing infection in the central nervous system (CNS). These patients are adults. Two of the patients had other diseases affecting CNS and immune systems: neurocysticercosis and acquired immunodeficiency syndrome, respectively. Nucleotide sequence analysis showed that the OROV from the CSF of these patients belonged to genotype I. We show here that severe Oropouche disease is occurring during outbreaks of this virus in BrazilAmazonas Research Supporting Foundation (FAPEAM) [871/10, 887/10]Amazonas Research Supporting Foundation (FAPEAM